| Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States MJ Prados, Y Liu, H Jun, J Lam, S Mattke Alzheimer's & Dementia 18 (1), 142-151, 2022 | 19 | 2022 |
| Expected and diagnosed rates of mild cognitive impairment and dementia in the US Medicare population: observational analysis S Mattke, H Jun, E Chen, Y Liu, A Becker, C Wallick Alzheimer's Research & Therapy 15 (1), 128, 2023 | 15 | 2023 |
| Social security and retirement in fast-aging middle-income countries: Evidence from Korea H Jun The Journal of the Economics of Ageing 17, 100284, 2020 | 13 | 2020 |
| Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment J Lam, H Jun, SK Cho, M Hanson, S Mattke Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 10 | 2021 |
| Population aging and deepening income inequality in Korea SC Hong, HK Jun Panel for Korean Economic Analysis 19 (1), 72-114, 2013 | 9 | 2013 |
| Private insurance and mental health among older adults with multiple chronic conditions: a longitudinal analysis by race and ethnicity H Jun, E Aguila International Journal of Environmental Research and Public Health 18 (5), 2615, 2021 | 8 | 2021 |
| How Much Value Would a Treatment for Alzheimer’s Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy H Jun, SK Cho, ER Aliyev, S Mattke, SC Suen Current Alzheimer Research 17 (9), 819-822, 2020 | 8 | 2020 |
| Detection rates of mild cognitive impairment in primary care for the United States Medicare population Y Liu, H Jun, A Becker, C Wallick, S Mattke The Journal of Prevention of Alzheimer's Disease 11 (1), 7-12, 2024 | 4 | 2024 |
| Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests H Jun, SK Cho, J Yoong, S Mattke Annals of Geriatric Medicine and Research, 2021 | 3 | 2021 |
| Association of cash payment with intensity of opioid prescriptions SK Cho, H Jun, TJ Varisco, J Lam, JA Romley, J Li, JD Thornton Journal of the American Pharmacists Association 62 (4), 1224-1231. e5, 2022 | 2 | 2022 |
| Assessing the Preparedness of the Korean Healthcare System Infrastructure for an Alzheimer’s Treatment H Jun, SK Cho, J Yoong, S Mattke CESR Reports, 2020 | 2* | 2020 |
| State Department of Motor Vehicles reporting mandates of dementia diagnoses and dementia underdiagnosis H Jun, Y Liu, E Chen, A Becker, S Mattke JAMA Network Open 7 (4), e248889-e248889, 2024 | 1 | 2024 |
| The value of Medicare coverage on depressive symptoms among older immigrants H Jun, S Mattke, A Chen, E Aguila The Gerontologist 64 (2), gnad070, 2024 | 1 | 2024 |
| Projected savings to Canadian provincial budgets from reduced long-term care home utilization due to a disease-modifying Alzheimer’s treatment H Jun, Z Shi, S Mattke The Journal of Prevention of Alzheimer's Disease 11 (1), 179-184, 2024 | 1 | 2024 |
| Substitution of generic drugs and biosimilars SK Cho, H Jun JAMA Internal Medicine 181 (4), 567-568, 2021 | 1 | 2021 |
| Disparities in Access to Diagnostic Evaluation for Alzheimer’s Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study S Mattke, H Jun, S Chu, M Hanson Journal of Alzheimer's Disease, 1-12, 2024 | | 2024 |
| Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy S Mattke, H Jun, M Hanson, S Chu, JH Kordower, EM Reiman The Journal of Prevention of Alzheimer's Disease 11 (2), 303-309, 2024 | | 2024 |
| Nursing Home Staffing: Share Of Immigrant Certified Nursing Assistants Grew As US-Born Staff Numbers Fell, 2010–21: Study examines the numbers of immigrant certified nursing … H Jun, DC Grabowski Health Affairs 43 (1), 108-117, 2024 | | 2024 |
| Expected vs Diagnosed Rates of Mild Cognitive Impairment and Dementia in the US Medicare Population (S15. 010) S Mattke, H Jun, E Chen, Y Liu, A Becker, C Wallick Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Delays in access to an Alzheimer’s treatment for individuals dually eligible for Medicare and Medicaid in the US S Mattke, H Jun, S Chu, M Hanson Alzheimer's & Dementia 18, e061085, 2022 | | 2022 |
